The hallmark symptom of sickle cell anemia is pain, particularly episodes of sudden pain, sometimes called sickle cell crises ...
Beam Therapeutics Inc. (NASDAQ:BEAM) revealed new safety and efficacy data from its BEACON Phase 1/2 trial of BEAM-101 in ...
AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 g/dL for the ...
Sotagliflozin, a dual SGLT1/2 inhibitor, increased hemoglobin levels in patients with type 2 diabetes and chronic kidney ...
Chronic anemia can leave you feeling tired, weak, and unable to concentrate. It happens when your body doesn’t have enough ...
Neonatal anemia can have lasting impacts on the growth and development of children. Anemia is highly prevalent among pregnant ...
The two-year project aims to make anemia screening more accessible on a global scale, particularly in low-resource areas with ...
The treatment CS-101 uses innovative transformer Base Editing (tBE) technology to help people with severe diseases such as ...
Kanglin Biotechnology has raised $20 million in financing to advance the development of sickle cell gene therapy KL003.
Promising topline results from a phase 3B study show the efficacy and quality of life (QOL) improvements of iptacopan ...